Cases of rare blood clots identified after AstraZeneca Covid-19 jabs

Cases of rare blood clots identified after AstraZeneca Covid-19 jabs

Cases of rare blood clots identified after AstraZeneca Covid-19 jabs

The Dutch health ministry said that the country "must err on the side of caution" but that the vaccine was "safe" for use.

"There should be no doubt whatsoever about the safety of vaccines".

The UK's Medicines and Healthcare products Regulatory Agency, or MHRA, said in a statement that "Out of the 30 reports up to and including 24 March, sadly 7 have died".

CVST clots stop blood draining from the brain properly.

But experts have stressed that no link has been proven - and the benefits of getting the vaccine far outweighed any risks, given the dangers posed by Covid.

Professor Robin Shattock, an infections specialist and vaccinologist at Imperial College London, told Sky News: "It's really important to recognise that now there's no link to having the vaccine and having these very rare blood clots".

"We have not been advised at this time by ATAGI or the TGA to pause the rollout of the AstraZeneca vaccine in Australia". In late March, CSL Ltd. began domestic production of 50 million doses. This is only 12% of the adult population.

The Minister wrote in a letter to Parliament that he took this decision pending a further judgment by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency.

Spain had restricted the vaccine for under-65s, but it reversed its decision, extending the roll-out to those over 65, on Tuesday.

David Werring, a professor at University College London's Institute of Neurology, said that the unusual presentation of the cases in vaccinated people was creating concern about possible links with the shot.

However, Ireland's medicines watchdog has said that none of the reports notified described the type of disorder associated with concerns about the AstraZeneca vaccine.

Linda Bauld, professor at Edinburgh University, said: "It doesn't look from the behavioural response, the surveys I've seen, that it's affecting uptake in the United Kingdom and that's really important".

She added that all studies indicated the vaccine was safe and effective, while the fact different nations were reviewing their position was a sign that the "system was working".

The UK, which has rolled out coronavirus vaccines faster than other European nations, is particularly reliant on the AstraZeneca vaccine, which was developed by scientists at the University of Oxford.

To date, 31,301,267 people have had a first vaccine dose in the United Kingdom and 4,948,635 have had two doses.

On Thursday, Germany's immunisation commission, the STIKO, recommended that anyone younger than 60 who received an initial vaccination with AstraZeneca be given either Pfizer-BioNTech or Moderna shots as their second vaccine doses. Almost five million people have gotten their second jab.

Suspect Rams Car Into US Capitol Barricade, Killing 1 Officer
Big businesses side with Democrats in clash over voting rights